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Abstract
Background: The purpose of this study was to evaluate the effects of cigarette smoke exposure before pregnancy
on diabetic rats and their offspring development.
Methods: Diabetes was induced by streptozotocin and cigarette smoke exposure was conducted by mainstream
smoke generated by a mechanical smoking device and delivered into a chamber. Diabetic female Wistar rats were
randomly distributed in four experimental groups (n minimum = 13/group): nondiabetic (ND) and diabetic rats
exposed to filtered air (D), diabetic rats exposed to cigarette smoke prior to and into the pregnancy period (DS)
and diabetic rats exposed to cigarette smoke prior to pregnancy period (DSPP). At day 21 of pregnancy, rats were
killed for maternal biochemical determination and reproductive outcomes.
Results: The association of diabetes and cigarette smoke in DSPP group caused altered glycemia at term, reduced
number of implantation and live fetuses, decreased litter and maternal weight, increased pre and postimplantation
loss rates, reduced triglyceride and VLDL-c concentrations, increased levels of thiol groups and MDA. Besides, these
dams presented increased SOD and GSH-Px activities. However, the increased antioxidant status was not sufficient
to prevent the lipid peroxidation observed in these animals.
Conclusion: Despite the benefits stemming from smoking interruption during the pregnancy of diabetic rats, such
improvement was insufficient to avoid metabolic alterations and provide an adequate intrauterine environment for
embryofetal development. Therefore, these results suggest that it is necessary to cease smoking extensive time
before planning pregnancy, since stopping smoking only when pregnancy is detected may not contribute
effectively to fully adequate embryofetal development.
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Background
Diabetes mellitus (DM) is a group of diseases character-
ized by high blood glucose levels that result from defects
in the body’s ability to produce and/or use insulin [1]. In
pregnancies complicated by diabetes, hyperglycemia and
lipid metabolism alterations are associated with both
maternal and fetal complications [2,3], causing reproduc-
tive abnormalities that enhance spontaneous abortion,
congenital anomalies, and neonatal morbidity and mor-
tality [4,5]. Oxidative stress has been implicated as a
contributor to both the onset and the progression of
diabetes and its associated complications. Some of the
consequences of an oxidative environment are the devel-
opment of insulin resistance, b-cell dysfunction, impaired
glucose tolerance, and mitochondrial dysfunction, which
can lead ultimately to the diabetic disease state. Experi-
mental and clinical data suggest an inverse association
between insulin sensitivity and ROS levels [6].
DM is a risk factor for atherosclerotic diseases, which
can be aggravated by the presence of arterial hypertension,
dyslipidemia and cigarette consumption [7]. It is a well-
known fact that cigarette smoking constitutes a significant
health hazard [8]. It has long been established that mater-
nal smoking during pregnancy has adverse consequences
for both the mother and the child [9,10]. The toxic effect
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bolic status is indicated by the significant disturbance of
the antioxidant status in newborns exposed in utero to
tobacco smoke [11]. A significant negative correlation has
been observed between the number of cigarettes smoked
per day by pregnant women and newborns’ weight, body
mass index, length and head circumference [12].
Experimental diabetes induced by b-cytotoxic drug
administration, such as streptozotocin, during the adult
life of laboratory animals causes severe diabetic clinical
status that reproduces uncontrolled human DM1. Severe
diabetes (glycemia superior to 300 mg/dL) causes mater-
nal hypertriglyceridemia and hypercholesterolemia,
which compromises maternal-fetal metabolism during
pregnancy in rats [13-15]. It causes increased maternal
oxidative stress [14], increased rate of pre and post-
implantation embryonic losses [16] and intrauterine
growth restriction (IUGR) [17,18]. Diabetic rats exposed
to cigarette smoke before and during pregnancy pre-
sented placentomegaly, increased placental index, small
fetuses for pregnancy age [16] and decreased liver glyco-
gen concentrations [19].
de Souza and colleagues [15] verified the association of
severe diabetes and exposure to cigarette smoke into rat
pregnancy was related to the incidence of hypertriglyceri-
demia, and this result was due to the diabetes and not to
exposure to smoke. There was no alteration to protein
metabolism at term pregnancy. Diabetes and cigarette
smoke exposure led to the activation of the antioxidant
system in an attempt to detoxify the organism in face of
high lipid peroxidation, which can be characterized by
the determination of reactive substances to thiobarbituric
acid.
However, there are no reports concerning the associa-
tion of diabetes and cigarette smoke exposure in rats that
stopped being exposed to tobacco smoke in the pregnancy,
aiming to reproduce the status of gravid women who
stopped smoking when pregnancy is detected. Hence, the
aim of this study was to evaluate the effects of such asso-
ciation on the maternal organism and on the development
of offspring.
Methods
1. Animals and experimental groups
Six-week-old female and nine-week-old male Wistar rats,
weighing approximately 190 g and 220 g respectively,
were obtained from Unesp - Universidade Estadual Pau-
lista. During the two-week acclimatization and the
experimental exposure periods, the rodents (5 rats per
cage) were maintained in an experimental room under
controlled conditions of temperature (22 ± 2°C), humid-
ity (50 ± 10%), and a 12-hour light/dark cycle with ad
libitum access to commercial diet (Purina
® rat chow
Brazil) and tap water. Rats were randomly distributed
into four groups (n minimum = 15/group): nondiabetic
(ND) and diabetic rats exposed to filtered air (D), diabetic
rats exposed to cigarette smoke prior to and into the
pregnancy period (DS) and diabetic rats exposed to cigar-
ette smoke prior to pregnancy period (pre-pregnancy)
(DSPP). The Ethics Committee for Experimental Animal
Research of the Botucatu School of Medicine/Unesp
approved of the protocols used in this study.
2. Experimental design
The experimental design (Figure 1) for association of the
diabetes and cigarette smoke exposure in rats was modi-
fied by Lima and colleagues [20].
A commercially available non-filter cigarette was used.
Each cigarette contained 10 mg of tar, 0.80 mg of nicotine
and 10 mg of carbon monoxide. Cigarette smoke exposure
was conducted by mainstream smoke generated by a
mechanical smoking device and delivered into a chamber
(Figure 2). In the first moment (cigarette smoke adaptation
period), non-pregnant rats were placed into whole-body
exposure chambers to adapt to filtered air (control) or to
cigarette smoke for 30 min (minutes), once a day (5 cigar-
ettes/day), for 7 days. After adaptation to cigarette smoke
exposure, the animals were placed into a chamber and
exposed to smoke equivalent of 20 cigarettes/day for
30 min, 2 times each day, 7 consecutive days per week, for
in turn 6 weeks. Each cigarette was puffed 15 times for
3 min at a rate of 5 puffs/min. Fresh air inhalation was
performed for 1 min after every 3 min of cigarette smoke
exposure. During the experiment, carbon monoxide was
controlled in turn 195 ppm (particles/million), the tem-
perature was maintained at 22-25°C, and relative humidity
was approximately 40%. This protocol is similar to 3-4
pack/day in a human, considering the carboxyhemoglobin
levels. The nondiabetic and diabetic rats exposed to fil-
tered air were submitted to similar methodology but free
of the cigarette smoke [21].
3. Induction of diabetes
Approximately six weeks after the beginning of the expo-
sure to the air or cigarette smoke exposure, diabetes was
induced by streptozotocin (STZ - SIGMA Chemical
Company, St. Louis, Millstone). STZ was dissolved in
citrate buffer (0.1 M, pH 6.5) and administered by intra-
venous (i.v.) injection at a dose of 40 mg/kg body weight
(D, DS and DSPP). Non-diabetic (control) rats received
(i.v.) only citrate buffer. During the induction of diabetes
the animals are continuous being exposed to cigarette
smoke/filtered air. For inclusion criteria, the diabetic
dams showed glycemia superior to 300 mg/dL seven days
after STZ injection, which is compatible with severe dia-
betes[22].
Damasceno et al. Diabetology & Metabolic Syndrome 2011, 3:20
http://www.dmsjournal.com/content/3/1/20
Page 2 of 8Figure 1 Experimental design for association of the diabetes and mainstream cigarette smoke exposure. ND = nondiabetic rats exposed
to filtered air, D = diabetic rats exposed to filtered air; DS = diabetic rats exposed to cigarette smoke prior to and during pregnancy; DSPP =
diabetic rats only exposed to cigarette smoke prior to pregnancy.
Figure 2 Mainstream cigarette smoke apparatus in rats.
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All female rats (ND, D, DS and DSPP) were mated over-
night to nondiabetic male rats unexposed to cigarette
smoke. The morning when sperm was found in the vagi-
nal smear was designated gestational day 0. The mating
procedure consisted of 15 consecutive days, a period
comprising approximately three estral cycles, until a
replicate number of groups were obtained. However, in
this period non-mated female rats were considered to be
infertile and discarded from the study. The DSPP group
stopped to be exposed to cigarette smoke at day zero of
pregnancy and the DS (cigarette smoke), ND and D (fil-
tered air) groups ended this exposure at the 21st day of
pregnancy.
5. Course of pregnancy
Glycemia was measured at days 0 and 21 of pregnancy in
all experimental groups. At day 21 of pregnancy, the dams
were weighed for estimation of body weight gain (maternal
weight at day 21 minus maternal weight at day 0 of preg-
nancy) and were given an overdose of sodium pentobarbi-
tal (Hypnol
® 3%) for laparotomy and collection of blood
samples for biochemical determinations. The uterus was
removed and weighed, and the ovaries and uterine con-
tents examined to determine the number of corpora lutea
and implantation sites, resorptions (embryonic death), and
number and position of viable fetuses. The rate of embryo-
nic loss before implantation was calculated as: (number of
corpora lutea - number of implantations) × 100/number
of corpora lutea, and used as a measure of failing concep-
tion effect or pre-implantation loss. The percentage of
embryonic loss after implantation was calculated as: (num-
ber of implantations - number of live fetuses) × 100/num-
ber of implantations, which was used as a measure of
abortifacient effect or for identification of post-implanta-
tion loss [23]. In the lack of visible implantation sites, the
uterine corns were stained with a preparation of 10%
ammonium sulphate [24]. Immediately after exploratory
laparotomy, all viable fetuses and placentas were weighed
for determination of the placental index (placental weight/
fetal weight) [25].
6. Biochemical measurements
The blood samples were divided in two ways: one por-
tion of blood was put into anticoagulant-free test tubes
and in others containing anticoagulant. The blood sam-
ples without anticoagulant were kept at low temperature
for 30 minutes (min) and then centrifuged at 1,300 × g
for 10 min at 4°C. The supernatant was collected as
serum and stored at -80°C for determination of total
cholesterol (and fractions), triglycerides and proteins
were determined by Wiener
® assay kit.
The blood samples were put into anticoagulant tubes,
centrifuged at 900 × g for 10 min at room temperature
for assay of oxidative stress biomarkers, which were esti-
mated in the washed erythrocytes. The oxidative stress
biomarkers evaluated were superoxide dismutase (SOD),
thiol groups and malonaldehide (MDA). MDA was mea-
sured as the lipid peroxidation index. SOD enzymatic
activity unit was defined as SOD units able to produce
50% of pyrogallol oxidation inhibition. All data were
expressed in units of SOD per milligram of hemoglobin.
Thiol groups was enzymatically determined using 5,5’-
dithio-bis (2-nitrobenzoic acid) (DTNB) and glutathione
reductase in the presence of a reduced form of nicotina-
mide adenine dinucleotide phosphate (NADPH), forming
2-nitro-5-thiobenzoic acid. Thiol group concentration
was measured at 412 nm on a spectrophotometer.
One unit of its activity was equal to the micromolar of
substrate reduced per gram of hemoglobin. For MDA
concentration, the absorbance was measured at a wave-
length of 535 nm, and the results were expressed as nM
of MDA per gram of hemoglobin (nM/g Hb) [15].
7. Statistical analysis
The glycemic levels and maternal reproductive outcomes
were expressed as mean ± standard deviation, and other
biochemical data were reported as mean ± standard error
of mean. The results of glycemia, lipid and protein deter-
mination, oxidative stress status (for MDA and SOD), and
maternal reproductive outcomes (for litter weight, mater-
nal weight gain, fetal and placental weights) were analyzed
by Tukey multiple comparison test [26]. When data
presented no symmetrical distribution and homogenize
variance, Gamma distribution was used (for pre- and post-
implantation loss rates, GSH-Px and thiol groups). Poisson
regression was applied for implantation sites, live fetuses,
corpora lutea numbers. Statistical significance was consid-
ered as p < 0.05. All data were evaluated according to help
of the statistical professional.
Results
1. Maternal glycemia during pregnancy
The diabetic rats (D, DS and DSPP) presented increased
glycemia (p < 0.05) in relation with nondiabetic rats at
beginning and at term pregnancy. The rats exposed to
cigarette smoke prior to and into the pregnancy period
(DS) presented increased levels of glycemia only at day 21
of pregnancy as compared to D group (Figure 3) (p <
0.05).
2. Maternal reproductive outcomes
In DS and DSPP dams, there was reduced number of
implantation (8.25 ± 3.50 and 7.57 ± 3.57), live fetus
number (7.25 ± 3.41 and 6.36 ± 4.27), litter weight
(49.63 ± 18.07 and 46.05 ± 20.89) and maternal weight
gain (73.31 ± 21.24 and 46.58 ± 48.61); and increase (p
< 0.05) in preimplantation loss rate (32.43% and
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live fetuses = 12.18 ± 0.90; litter weight = 84.21 ± 6.98;
maternal weight gain = 133.09 ± 14.99; preimplantation
loss rate = 5.97%) and D (12.00 ± 1.26; 10.90 ± 0.70;
73.31 ± 4.99; 107.38 ± 12.07; 6.36%) groups, respec-
tively. The diabetic rats (D, DS and DSPP) presented
decreased fetal weight (approximately 4.4 ± 0.5) and
increased placental weight (approximately 0.62 ± 0.10)
(p < 0.05) as compared to ND group (5.31 ± 0.29; 0.48
± 0.03), respectively. The rates of postimplantation loss
in DS and DSPP (13.26% and 27.85%) were higher in
relation with ND group (2.72%), and this rate was
i n c r e a s e di nD S P P( 2 7 . 8 5 % )a sc o m p a r e dt oDg r o u p
(6.35%) (Table 1).
3. Biochemical measurements
The biochemical parameters evaluated at day 21 of preg-
nancy are presented in Table 2. The D rats presented
increase in VLDL-c, triglycerides, total cholesterol and
MDA levels as compared to ND group. The DS dams
showed increased determinations of HDL-c, VLDL-c, tri-
glycerides, MDA, and activities of GSH-Px and SOD in
relation with ND group; besides HDL-c level and GSH-Px
activity were also increased as compared to values from D
group. The DSPP dams exhibited significant statistically
increase in MDA and thiol group levels, SOD and GSH-Px
activities in relation with ND rats. As compared to D
group, the DSPP rats presented reduction in the VLDL-c
and triglycerides levels and increase in the thiol group
levels and SOD activity. DSPP also showed an increased
thiol group measurement as compared to level from DS
group.
Discussion
Cigarette smoke exposure did not significantly exacer-
bate the hyperglycemia in diabetic groups at day 0 of
pregnancy, corroborating with other investigations per-
formed in our laboratory, which verified that rats
exposed to cigarette smoke prior to and during preg-
nancy presented glycemia similar to diabetic dams
[15,20]. However, our study showed an increased glyce-
mia in the end of pregnancy in diabetic rats exposed to
cigarette smoke prior to and the pregnancy period.
The analysis of maternal reproductive performance was
aggravated in the diabetes/cigarette smoke association,
regardless of the exposure moments. The number of
implanted embryos and of live fetuses that developed was
lower in the groups of rats submitted to the association of
two variables, thus contributing to reduction of the litter
weight. de Souza et al [16] also observed these alterations
in the diabetic rats exposed to cigarette smoke prior to
and into pregnancy period. The embryonic loss rate prior
to implantation depends on the number of corpora lutea
and implantation sites. In this study, it was observed that
the number of implantation sites was smaller in groups
DS and DSPP, leading to increased percentages of preim-
plantation loss in the respective groups. For an embryonic
fixation (embryonic implantation) to occur in the gravid
endometrium there must be a synchronism between the
maternal organism and embryonic development. The
cigarette contains high levels of toxic substances that may
accumulate in reproductive organs, thus contributing to
impair the embryonic implantation process. By this way,
studies indicates that smoking one pack of cigarettes per
day and starting to smoke before 18 years of age is asso-
ciated with an increased risk of infertility in females [27].
The rats that were submitted to cigarette smoke exposure
prior to pregnancy period (DSPP) showed fetal viability
reduction, similarly to those which continued being
exposed during the whole experiment (DS). The post
implantation loss rates were increased after the diabetes/
tobacco smoke association, but these results were aggra-
vated when the rats abruptly stopped being exposed to
cigarette smoke, suggesting an increased inflammatory
reaction due to elevation of cortisol caused by abstinence
syndrome.
In the present study, cigarette smoke exposure prior to
pregnancy did not improve reduction of fetal weights from
diabetic dams exposed to cigarette smoke before and dur-
ing pregnancy, showing that stop to being exposed pre-
vious moments of pregnancy is not enough. It is known
that decreased weight at birth presents a direct relation
between the number of cigarettes smoked, carbon-monox-
ide concentration and cigarette tar content. However,
despite the numerous investigations, the mechanism by
which smoking interferes with fetal development remains
unclear. The offspring of women who smoked during
Figure 3 Maternal glycemia (mg/dL) at days 0 and 21 of
pregnancy in the different experimental groups. Values are
expressed as mean ± standard deviation (SD). ND = nondiabetic rats
exposed to filtered air, D = diabetic rats exposed to filtered air; DS =
diabetic rats exposed to cigarette smoke prior to and during
pregnancy; DSPP = diabetic rats only exposed to cigarette smoke
prior to pregnancy. * p < 0.05 - significant statistically difference as
compared to ND group;
# p < 0.05 - significant statistically difference
as compared to D group (Tukey multiple comparison test).
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their organisms which are harmful to their development.
Such newborns usually present lower birth weight, are less
developed and more vulnerable to diseases, including
asthma and even cancer [28]. Data have shown an associa-
tion between abnormal fetal growth and both active [29]
or passive [30] cigarette smoke exposure during gestation.
Esposito and colleagues [31] identified a temporal window
of vulnerability during the pre/peri-implantation period of
embryonic development for in utero smoke-exposure-
induced low birth weight. Further, these studies documen-
ted the establishment of a viable animal model with which
to test hypotheses regarding the cellular and molecular
mechanisms underlying gestational low birth weight
induced by tobacco-smoke exposure.
Previous study performed in our laboratory verified
that diabetic rats (D) presented high levels of triglycerides
and total cholesterol [15]. In our paper, the rats that
stopped smoking prior to pregnancy period (DSPP)
showed decreased triglyceride levels, and consequently
r e d u c t i o ni nt h eV L D L - cl e v e l s .H o w e v e r ,t h er e d u c e d
level of this lipid was not sufficient to characterize a total
improved lipid profile in these animals. Besides, the total
cholesterol tended to increase in diabetic dams and dia-
betes and cigarette association group. These animals also
presented high level of MDA, thus elevated lipoperoxida-
tion (exacerbated oxidative stress status), contributing to
an adverse intrauterine environment, which led to an
impaired embryofetal development (reduced number of
implantations and live fetuses). In our paper, the rats that
Table 1 Maternal reproductive outcome evaluated at day 21 of pregnancy from different experimental groups
Variables Groups
ND (n = 15) D (n = 15) DS (n = 15) DSPP (n = 17)
No. of corpora lutea
a 13.54 ± 1.03 12.81 ± 1.72 12.08 ± 1.62 11.71 ± 2.84
No. of implantation sites
a 12.63 ± 0.80 12.00 ± 1.26 8.25 ± 3.50*
# 7.57 ± 3.57*
#
No. of live fetuses
a 12.18 ± 0.90 10.90 ± 0.70 7.25 ± 3.41*
# 6.36 ± 4.27*
#
Litter weight
b 84.21 ± 6.98 73.31 ± 4.99 49.63 ± 18.07*
# 46.05 ± 20.89*
#
Maternal Weight Gain
b 133.09 ± 14.99 107.38 ± 12.07 73.31 ± 21.24*
# 46.58 ± 48.61*
#
Fetal weight
b 5.31 ± 0.29 4.41 ± 0.52* 4.49 ± 0.30* 4.23 ± 0.85*
Placental weight
b 0.48 ± 0.03 0.61 ± 0.07* 0.62 ± 0.13* 0.66 ± 0.29*
Preimplantation loss (%)
c 5.97 6.36 32.43*
# 33.69*
#
Postimplantation loss (%)
c 2.72 6.35 13.26* 27.85*
#
Values are expressed as mean ± standard deviation (SD).
ND = nondiabetic rats exposed to filtered air, D = diabetic rats exposed to filtered air; DS = diabetic rats exposed to cigarette smoke prior to and during
pregnancy; DSPP = diabetic rats only exposed to cigarette smoke prior to pregnancy.
* p < 0.05 - significant statistically difference as compared to ND group;
#p < 0.05 - significant statistically difference as compared to D group.
aZero - Inflated
Poisson;
bNormal distribution (Tukey Multiple Comparison test), and
cGamma distribution.
Table 2 Biochemical measurements evaluated at day 21 of pregnancy from different experimental groups
Variables Groups
ND (n = 15) D (n = 15) DS (n = 15) DSPP (n = 17)
HDL-c
(mg/dL)
a
32.21 ± 7.88 43.84 ± 4.71 94.86 ± 9.31*
# 66.10 ± 7.65
VLDL-c
(mg/dL)
a
66.23 ± 5.35 304.63 ± 33.24* 206.91 ± 23.63* 170.90 ± 27.79
#
Triglycerides (mg/dL)
a 331.16 ± 26.81 1523.16 ± 166.22* 1034.53 ± 118.16* 854.61 ± 138.97
#
Total cholesterol (mg/dL)
a 118.15 ± 5.97 287.57 ± 38.01* 226.60 ± 21.99 238.22 ± 33.65
Total protein (g/dL)
a 6.73 ± 0.7714 7.30 ± 0.53 5.60 ± 0.56 7.08 ± 0.80
MDA
(nM/g Hb)
a
49.85 ± 4.18 686.84 ± 298.35* 451.14 ± 119.61* 696.03 ± 86.37*
SOD
(U/mg Hb)
a
1.78 ± 0.30 11.64 ± 4.23 17.48 ± 2.59* 22.19 ± 1.44*
#
GSH-Px
(U/mg Hb)
b
0.08 ± 0.03 0.35 ± 0.15 1.83 ± 0.53*
# 1.60 ± 0.15*
Thiol groups (μM/g Hb)
b 1.19 ± 0.47 3.81 ± 0.95 5.52 ± 0.44 24.54 ± 5.23*
#$
Values are expressed as mean ± standard error of mean (SEM).
ND = nondiabetic rats exposed to filtered air, D = diabetic rats exposed to filtered air; DS = diabetic rats exposed to cigarette smoke prior to and during
pregnancy; DSPP = diabetic rats only exposed to cigarette smoke prior to pregnancy.
*p < 0.05 - significant statistically difference as compared to ND group;
#p < 0.05 - significant statistically difference as compared to D group;
$p < 0.05 -
significant statistically difference as compared to DS group.
aNormal distribution (Tukey Multiple Comparison test) and
bGamma distribution.
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showed a tendency to increase SOD activity and signifi-
cant increase in levels of thiol groups. We suggested that
the abstinence syndrome status caused metabolism
alterations, which exacerbated oxidative stress, but the
increase of antioxidants (thiol groups) status was not suf-
ficient to prevent the lipid peroxidation observed in these
animals. In physiologic concentrations, ROS help to
maintain homeostasis. However, when ROS accumulate
in excess for prolonged periods of time, they cause
chronic oxidative stress and adverse effects [32].
This data confirmed that stopping smoking prior to
pregnancy period presented similar data as compared to
be submitted to cigarette smoke before and during preg-
nancy. In conclusion, despite the benefits stemming from
smoking interruption during the pregnancy of diabetic
rats, such improvement was insufficient to avoid metabolic
alterations and provide an adequate intrauterine environ-
ment for embryofetal development. Therefore, these
results suggest that it is necessary to cease smoking exten-
sive time before planning pregnancy since stopping smok-
ing only when pregnancy is detected may not contribute
effectively to fully adequate embryofetal development.
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